Waystar Considers Sale Amid Declining Market Value, Sources Reveal
Healthcare software firm Waystar is exploring strategic options, including a possible sale, following a significant drop in its market value.
Waystar, a healthcare software company known for its payment management technology used by hospitals and doctors, is reportedly exploring strategic options, which may include a sale. According to seven sources familiar with the situation, this move comes two years after the company went public in New York. Investment bank Evercore has been engaged to advise on the process, though discussions remain in preliminary stages, and no definitive decisions have been made.
The company, headquartered in Lehi, Utah, and Louisville, Kentucky, has seen its market value decline to approximately $4.8 billion, following a 24% drop in its share price this year. This decline is part of a broader downturn affecting the software sector. The potential sale could gauge whether investor interest in software companies is reviving.
Strategic Positioning and Market Challenges
Waystar has been positioning itself as a technology-driven company by focusing on automating and managing administrative healthcare tasks. This strategy aimed to achieve higher valuations typically associated with technology firms. Initially, investors responded positively, driving the stock price from $20 to a peak of $45 in 2025. However, concerns over the impact of artificial intelligence advancements on software companies have since pressured the stock, as noted by Morgan Stanley analysts in a July report.
The company was formed in 2017 through the merger of revenue management entities Zirmed and Navicure. Its major stakeholders include EQT, the Canada Pension Plan Investment Board (CPPIB), and Bain Capital, which facilitated its public listing in 2024. EQT holds a 13% stake, CPPIB 10%, and BlackRock Institutional Trust Company 8%, according to data from LSEG.
Stakeholder Reactions and Market Speculation
Despite the ongoing evaluation of strategic options, including a potential sale, Waystar has declined to comment on the matter. Similarly, EQT and BlackRock have not provided statements, while CPPIB has not yet responded to inquiries. The involvement of Evercore suggests a methodical approach to exploring these options, although the outcome remains uncertain.
The exploration of a sale underscores the challenges faced by software companies in maintaining investor confidence amid technological disruptions and sector-wide volatility. This situation presents a critical moment for Waystar as it navigates potential changes in ownership and strategic direction.